Condition
Chordee
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05708989Phase 4Withdrawn
Caudal vs. Pudendal Block in Peds GU
NCT04826484Phase 3Terminated
Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel
NCT04755803Completed
A Prospective Registry of Patients With Congenital Penile Anomalies
NCT04636476Not ApplicableCompleted
One Stage Correction of Congenital Penile Curvature Complex
NCT04605068Not ApplicableCompleted
Transverse Preputial Island Flap Versus Double Faced Preputial Flap for Repair of Penoscrotal Hypospadias With Chordee
Showing all 5 trials